Literature DB >> 11071460

Management of biofilm infections in the urinary tract.

H Kumon1.   

Abstract

Bacterial biofilms develop on a number of living and inert surfaces within the urinary tract, producing chronic intractable infections. The role of exopolysaccharides in producing a variety of extracellular polymeric substances according to the infection site and bacterial species and the clinical features of the resulting biofilm infections were reviewed. Although fluoroquinolone shows a considerable killing effect against bacterial biofilm, no commercially available drugs are sufficiently active against the cells in a mature biofilm. Combination therapy of fluoroquinolone and macrolide or fluoroquinolone and fosfomycin may be the most effective regimen available at present. Nevertheless, management of the local urinary condition and removal of the local underlying disease are the most effective approaches to treating urinary biofilm infection.

Entities:  

Mesh:

Year:  2000        PMID: 11071460     DOI: 10.1007/s002680010203

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  9 in total

1.  Urinary bactericidal activity of extended-release ciprofloxacin (1,000 milligrams) versus levofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.

Authors:  Florian M E Wagenlehner; Martina Kinzig-Schippers; Uwe Tischmeyer; Christine Wagenlehner; Fritz Sörgel; Kurt G Naber
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

Review 2.  Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972.

Authors:  Per Klemm; Viktoria Hancock; Mark A Schembri
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

Review 3.  Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 4.  Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis.

Authors:  Florian M E Wagenlehner; Wolfgang Weidner; Kurt G Naber
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

5.  Noninvasive biophotonic imaging for monitoring of catheter-associated urinary tract infections and therapy in mice.

Authors:  Jagath L Kadurugamuwa; Kshitij Modi; Jun Yu; Kevin P Francis; Tony Purchio; Pamela R Contag
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  Antibiotic susceptibility of coagulase-negative staphylococci isolated from very low birth weight babies: comprehensive comparisons of bacteria at different stages of biofilm formation.

Authors:  Yue Qu; Andrew J Daley; Taghrid S Istivan; Suzanne M Garland; Margaret A Deighton
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-05-27       Impact factor: 3.944

Review 7.  Antibiotic alternatives: the substitution of antibiotics in animal husbandry?

Authors:  Guyue Cheng; Haihong Hao; Shuyu Xie; Xu Wang; Menghong Dai; Lingli Huang; Zonghui Yuan
Journal:  Front Microbiol       Date:  2014-05-13       Impact factor: 5.640

8.  Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rectal flora.

Authors:  Do Gyeong Lim; Seung Il Jung; Myung Soo Kim; Ho Seok Chung; Eu Chang Hwang; Dong Deuk Kwon
Journal:  Prostate Int       Date:  2021-04-17

9.  The impact of urinary bladder catheterisation after ureterorenoscopic stone removal on the postoperative course.

Authors:  Emilia Pawłowska-Krajka; Adam Dorobek
Journal:  Cent European J Urol       Date:  2017-10-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.